Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3685)
All Articles published online
|
Sep 14, 2005 (publication date) through Dec 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Qiu WH, Zhou BS, Chu PG, Chen WG, Chung C, Shih J, Hwu P, Yeh C, Lopez R, Yen Y. Over-expression of fibroblast growth factor receptor 3 in human hepatocellular carcinoma. World J Gastroenterol 2005; 11(34): 5266-5272 [PMID: 16149130 DOI: 10.3748/wjg.v11.i34.5266] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i34/5266.htm |
| Number | Citing Articles |
| 1 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_173-1
|
| 2 |
Chongsen Zang, Zixuan Liu, Kunmeng Yang, Rui Li, Xinxin Wang, Jizhou Zhang, Yechen Xiao. Expression, purification and biological effect of a novel single chain Fv antibody and protamine fusion protein for the targeted delivery of siRNAs to FGFR3 positive cancer cells. Electronic Journal of Biotechnology 2017; 28: 14 doi: 10.1016/j.ejbt.2017.05.009
|
| 3 |
Guiji Zhang, Xia Tang, Li Liang, Wanfeng Zhang, Dewei Li, Xiaoyuan Li, Dachun Zhao, Yaqiu Zheng, Yanhong Chen, Bingtao Hao, Kai Wang, Ni Tang, Keyue Ding. DNA and RNA sequencing identified a novel oncogene VPS35 in liver hepatocellular carcinoma. Oncogene 2020; 39(16): 3229 doi: 10.1038/s41388-020-1215-6
|
| 4 |
Mélanie Mahe, Florent Dufour, Hélène Neyret‐Kahn, Aura Moreno‐Vega, Claire Beraud, Mingjun Shi, Imene Hamaidi, Virginia Sanchez‐Quiles, Clementine Krucker, Marion Dorland‐Galliot, Elodie Chapeaublanc, Remy Nicolle, Hervé Lang, Celio Pouponnot, Thierry Massfelder, François Radvanyi, Isabelle Bernard‐Pierrot.
An
FGFR
3/
MYC
positive feedback loop provides new opportunities for targeted therapies in bladder cancers
. EMBO Molecular Medicine 2018; 10(4) doi: 10.15252/emmm.201708163
|
| 5 |
Yunju Nam, Injae Shin, Younghoon Kim, SeongShick Ryu, Namdoo Kim, Eunhye Ju, Taebo Sim. Anti-cancer effects of 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one derivatives on hepatocellular carcinoma harboring FGFR4 activation. Neoplasia 2022; 24(1): 34 doi: 10.1016/j.neo.2021.11.011
|
| 6 |
Keyang Chen, Zhiheng Rao, Siyang Dong, Yajing Chen, Xulan Wang, Yongde Luo, Fanghua Gong, Xiaokun Li. Roles of the fibroblast growth factor signal transduction system in tissue injury repair. Burns & Trauma 2022; 10 doi: 10.1093/burnst/tkac005
|
| 7 |
Xiangnan Du, Qian-Rena Wang, Emily Chan, Mark Merchant, Jinfeng Liu, Dorothy French, Avi Ashkenazi, Jing Qing. FGFR3 Stimulates Stearoyl CoA Desaturase 1 Activity to Promote Bladder Tumor Growth. Cancer Research 2012; 72(22): 5843 doi: 10.1158/0008-5472.CAN-12-1329
|
| 8 |
Ke Cao, Weidong Liu, Hideji Nakamura, Hirayuki Enomoto, Teruhisa Yamamoto, Masaki Saito, Hiroyasu Imanishi, Soji Shimomura, Peiguo Cao, Shuhei Nishiguchi. Vitamin K2 downregulates the expression of fibroblast growth factor receptor 3 in human hepatocellular carcinoma cells. Hepatology Research 2009; 39(11): 1108 doi: 10.1111/j.1872-034X.2009.00536.x
|
| 9 |
Nobuyuki Itoh, Yoshiaki Nakayama, Morichika Konishi. Roles of FGFs As Paracrine or Endocrine Signals in Liver Development, Health, and Disease. Frontiers in Cell and Developmental Biology 2016; 4 doi: 10.3389/fcell.2016.00030
|
| 10 |
Gareth S. Baynam, Jack Goldblatt. A Child With an FGFR3 Mutation, a Laterality Disorder and an Hepatoblastoma: Novel Associations and Possible Gene–Environment Interactions. Twin Research and Human Genetics 2010; 13(4): 297 doi: 10.1375/twin.13.4.297
|
| 11 |
Rushabh Gujarathi, Joseph W. Franses, Anjana Pillai, Chih-Yi Liao. Targeted therapies in hepatocellular carcinoma: past, present, and future. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1432423
|
| 12 |
Aldo Prawira, Thi Bich Uyen Le, Rebecca Zhi Wen Ho, Hung Huynh. Upregulation of the ErbB family by EZH2 in hepatocellular carcinoma confers resistance to FGFR inhibitor. Journal of Cancer Research and Clinical Oncology 2021; 147(10): 2955 doi: 10.1007/s00432-021-03703-6
|
| 13 |
Nikolett Barta, Nóra Ördög, Vasiliki Pantazi, Ivett Berzsenyi, Barbara N. Borsos, Hajnalka Majoros, Zoltán G. Páhi, Zsuzsanna Ujfaludi, Tibor Pankotai. Identifying Suitable Reference Gene Candidates for Quantification of DNA Damage-Induced Cellular Responses in Human U2OS Cell Culture System. Biomolecules 2023; 13(10): 1523 doi: 10.3390/biom13101523
|
| 14 |
Zixuan Liu, Jizhou Zhang, Hongqiong Fan, Ruofeng Yin, Zhong Zheng, Qian Xu, Qing Liu, Haiting He, Xiaofan Peng, XinXin Wang, Xiaokun Li, Yechen Xiao. Expression and purification of soluble single-chain Fv against human fibroblast growth factor receptor 3 fused with Sumo tag in Escherichia coli. Electronic Journal of Biotechnology 2015; 18(4): 302 doi: 10.1016/j.ejbt.2015.05.006
|
| 15 |
Li Sheng, Jie Li, Bao-Tai Qi, Yu-Qiang Ji, Zhao-Jun Meng, Ming Xie. Investigation on correlation between expression of CD58 molecule and severity of hepatitis B. World Journal of Gastroenterology 2006; 12(26): 4237-4240 doi: 10.3748/wjg.v12.i26.4237
|
| 16 |
Natacha Entz-Werle, Thomas Lavaux, Nadia Metzger, Corinne Stoetzel, Christelle Lasthaus, Perrine Marec, Chantal Kalita, Laurence Brugieres, Helene Pacquement, Claudine Schmitt, Marie-Dominique Tabone, Jean-Claude Gentet, Patrick Lutz, Annie Babin, Pierre Oudet, Marie Pierre Gaub, Fabienne Perrin-Schmitt. Involvement of MET/TWIST/APC Combination or the Potential Role of Ossification Factors in Pediatric High-Grade Osteosarcoma Oncogenesis. Neoplasia 2007; 9(8): 678 doi: 10.1593/neo.07367
|
| 17 |
Koos Koole, Pauline M. W. van Kempen, Justin E. Swartz, Ton Peeters, Paul J. van Diest, Ron Koole, Robert J. J. van Es, Stefan M. Willems. Fibroblast growth factor receptor 3 protein is overexpressed in oral and oropharyngeal squamous cell carcinoma. Cancer Medicine 2016; 5(2): 275 doi: 10.1002/cam4.595
|
| 18 |
Jing Qing, Xiangnan Du, Yongmei Chen, Pamela Chan, Hao Li, Ping Wu, Scot Marsters, Scott Stawicki, Janet Tien, Klara Totpal, Sarajane Ross, Susanna Stinson, David Dornan, Dorothy French, Qian-Rena Wang, Jean-Philippe Stephan, Yan Wu, Christian Wiesmann, Avi Ashkenazi. Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in mice. Journal of Clinical Investigation 2009; 119(5): 1216 doi: 10.1172/JCI38017
|
| 19 |
Han Kiat Ho, Boon Tin Chua, Winnie Wong, Kah Suan Lim, Vivian Teo, Hooi-Tin Ong, Xiao Chen, Wei Zhang, Kam M. Hui, Mei Lin Go, Axel Ullrich. Benzylidene‐indolinones are effective as multi‐targeted kinase inhibitor therapeutics against hepatocellular carcinoma. Molecular Oncology 2014; 8(7): 1266 doi: 10.1016/j.molonc.2014.04.008
|
| 20 |
Xiaopeng Yan, Cong Shao, Chuang Chen, Jun Chen, Shen Gu, Luoshun Huang, Xu Fu, Hui Zhao, Yudong Qiu. Mutation Detection of Fibroblast Growth Factor Receptor 3 for Infiltrative Hepatocellular Carcinoma by Whole-Exome Sequencing. Digestive Diseases and Sciences 2017; 62(2): 407 doi: 10.1007/s10620-016-4408-7
|
| 21 |
Yarong Guo, Bao Chai, Junmei Jia, Mudan Yang, Yanjun Li, Rui Zhang, Shunmin Wang, Jun Xu. KLF7/VPS35 axis contributes to hepatocellular carcinoma progression through CCDC85C-activated β-catenin pathway. Cell & Bioscience 2021; 11(1) doi: 10.1186/s13578-021-00585-6
|
| 22 |
Pan Diao, Yaping Wang, Fangping Jia, Xiaojing Wang, Xiao Hu, Takefumi Kimura, Yoshiko Sato, Kyoji Moriya, Kazuhiko Koike, Jun Nakayama, Naoki Tanaka. Dietary Fat Composition Affects Hepatic Angiogenesis and Lymphangiogenesis in Hepatitis C Virus Core Gene Transgenic Mice. Liver Cancer 2023; 12(1): 57 doi: 10.1159/000525546
|
| 23 |
Kristine A. Drafahl, Christopher W. McAndrew, Daniel J. Donoghue. Handbook of Cell Signaling. 2010; : 1939 doi: 10.1016/B978-0-12-374145-5.00237-0
|
| 24 |
Claudio Luchini, Paola Capelli, Matteo Fassan, Michele Simbolo, Andrea Mafficini, Federica Pedica, Andrea Ruzzenente, Alfredo Guglielmi, Vincenzo Corbo, Aldo Scarpa. Next-Generation Histopathologic Diagnosis: A Lesson From a Hepatic Carcinosarcoma. Journal of Clinical Oncology 2014; 32(17): e63 doi: 10.1200/JCO.2012.47.5855
|
| 25 |
Ke Li, Baiyong Shen, Xi Cheng, Ding Ma, Xiaoqian Jing, Xinyu Liu, Weiping Yang, Chenghong Peng, Weihua Qiu. Phenotypic and Signaling Consequences of a Novel Aberrantly Spliced Transcript FGF Receptor-3 in Hepatocellular Carcinoma. Cancer Research 2016; 76(14): 4205 doi: 10.1158/0008-5472.CAN-15-3385
|
| 26 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 3159 doi: 10.1007/978-3-319-26956-6_173
|
| 27 |
Hyo Jeong Lee, Hyo Jeong Kang, Kang Mo Kim, Eun Sil Yu, Ki Hun Kim, Seung-Mi Kim, Tae Won Kim, Ju Hyun Shim, Young-Suk Lim, Han Chu Lee, Young-Hwa Chung, Yung Sang Lee. Fibroblast growth factor receptor isotype expression and its association with overall survival in patients with hepatocellular carcinoma. Clinical and Molecular Hepatology 2015; 21(1): 60 doi: 10.3350/cmh.2015.21.1.60
|
| 28 |
Jaleh Varshosaz, Maryam Farzan. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma. World Journal of Gastroenterology 2015; 21(42): 12022-12041 doi: 10.3748/wjg.v21.i42.12022
|
| 29 |
HIDEAKI MURASE, MIKITO INOKUCHI, YOKO TAKAGI, KEIJI KATO, KAZUYUKI KOJIMA, KENICHI SUGIHARA. Prognostic significance of the co-overexpression of fibroblast growth factor receptors 1, 2 and 4 in gastric cancer. Molecular and Clinical Oncology 2014; 2(4): 509 doi: 10.3892/mco.2014.293
|
| 30 |
Jorge L. Martínez-Torrecuadrada, Lawrence H. Cheung, Paula López-Serra, Rodrigo Barderas, Marta Cañamero, Sergio Ferreiro, Michael G. Rosenblum, J. Ignacio Casal. Antitumor activity of fibroblast growth factor receptor 3–specific immunotoxins in a xenograft mouse model of bladder carcinoma is mediated by apoptosis. Molecular Cancer Therapeutics 2008; 7(4): 862 doi: 10.1158/1535-7163.MCT-07-0394
|
| 31 |
Han Kiat Ho, Sharon Pok, Sylvia Streit, Jens E. Ruhe, Stefan Hart, Kah Suan Lim, Hooi Linn Loo, Myat Oo Aung, Seng Gee Lim, Axel Ullrich. Fibroblast growth factor receptor 4 regulates proliferation, anti-apoptosis and alpha-fetoprotein secretion during hepatocellular carcinoma progression and represents a potential target for therapeutic intervention. Journal of Hepatology 2009; 50(1): 118 doi: 10.1016/j.jhep.2008.08.015
|
| 32 |
Xiaoting Luo, Xin He, Xingmei Zhang, Xiaohui Zhao, Yuzhe Zhang, Yusheng Shi, Shengni Hua. Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy. MedComm 2024; 5(2) doi: 10.1002/mco2.474
|
| 33 |
Jae-Cheol Jo, Eun Kyoung Choi, Jae-Sik Shin, Jai-Hee Moon, Seung-Woo Hong, Ha-Reum Lee, Seung-Mi Kim, Soo-A Jung, Dae-Hee Lee, Seang Hwan Jung, Sun-Hye Lee, Jeong Eun Kim, Kyu-pyo Kim, Yong Sang Hong, Young-Ah Suh, Se Jin Jang, Eun Kyung Choi, Jung Shin Lee, Dong-Hoon Jin, Tae Won Kim. Targeting FGFR Pathway in Human Hepatocellular Carcinoma: Expressing pFGFR and pMET for Antitumor Activity. Molecular Cancer Therapeutics 2015; 14(11): 2613 doi: 10.1158/1535-7163.MCT-14-0780
|
| 34 |
Zhijian Jin, Haoran Feng, Juyong Liang, Xiaoqian Jing, Qiwu Zhao, Ling Zhan, Baiyong Shen, Xi Cheng, Liping Su, Weihua Qiu. FGFR3△7–9 promotes tumor progression via the phosphorylation and destabilization of ten-eleven translocation-2 in human hepatocellular carcinoma. Cell Death & Disease 2020; 11(10) doi: 10.1038/s41419-020-03089-2
|
| 35 |
SHI LIU, JIAN GONG, ASAHIRO MORISHITA, TAKAKO NOMURA, HISAAKI MIYOSHI, JOJI TANI, KIYOHITO KATO, HIROHITO YONEYAMA, AKIHIRO DEGUCHI, HIROHITO MORI, SHIMA MIMURA, KEI NOMURA, TAKASHI HIMOTO, KAZUSHI DEGUCHI, KEIICHI OKANO, KUNIHIKO IZUISHI, YASUYUKI SUZUKI, YOSHIO KUSHIDA, REIJI HABA, HISAKAZU IWAMA, TSUTOMU MASAKI. Use of protein array technology to investigate receptor tyrosine kinases activated in hepatocellular carcinoma. Experimental and Therapeutic Medicine 2011; 2(3): 399 doi: 10.3892/etm.2011.215
|
| 36 |
|
| 37 |
Oliver Hahn, Thomas M. Stubbs, Wolf Reik, Sebastian Grönke, Andreas Beyer, Linda Partridge, Gregory S. Barsh. Hepatic gene body hypermethylation is a shared epigenetic signature of murine longevity. PLOS Genetics 2018; 14(11): e1007766 doi: 10.1371/journal.pgen.1007766
|
| 38 |
Takeshi Goya, Kenichi Horisawa, Miyako Udono, Yasuyuki Ohkawa, Yoshihiro Ogawa, Sayaka Sekiya, Atsushi Suzuki. Direct Conversion of Human Endothelial Cells Into Liver Cancer‐Forming Cells Using Nonintegrative Episomal Vectors. Hepatology Communications 2022; 6(7): 1725 doi: 10.1002/hep4.1911
|
| 39 |
Xinyu Liu, Xiaoqian Jing, Xi Cheng, Ding Ma, Zhijian Jin, Weiping Yang, Weihua Qiu. FGFR3 promotes angiogenesis-dependent metastasis of hepatocellular carcinoma via facilitating MCP-1-mediated vascular formation. Medical Oncology 2016; 33(5) doi: 10.1007/s12032-016-0761-9
|
| 40 |
Dina H. El-Dahshan, Mohamed S. Omar, Ashraf M. Genena, Hamdy M. Zawwam. Fibroblast growth factor receptor 3 gene expression in Egyptian acute leukemia patients. Comparative Clinical Pathology 2014; 23(5): 1299 doi: 10.1007/s00580-013-1778-5
|
| 41 |
Jakob Paur, Lisa Nika, Christiane Maier, Alexander Moscu‐Gregor, Julia Kostka, Daniela Huber, Thomas Mohr, Petra Heffeter, Waltraud C. Schrottmaier, Sonja Kappel, Daniela Kandioler, Klaus Holzmann, Brigitte Marian, Walter Berger, Michael Grusch, Bettina Grasl‐Kraupp. Fibroblast growth factor receptor 3 isoforms: Novel therapeutic targets for hepatocellular carcinoma?. Hepatology 2015; 62(6): 1767 doi: 10.1002/hep.28023
|
| 42 |
Greta Pessino, Claudia Scotti, Maristella Maggi. Hepatocellular Carcinoma: Old and Emerging Therapeutic Targets. Cancers 2024; 16(5): 901 doi: 10.3390/cancers16050901
|
| 43 |
Mark A. Feitelson, Helena M.G.P.V. Reis, N. Lale Tufan, Bill Sun, Jingbo Pan, Zhaorui Lian. Putative roles of hepatitis B x antigen in the pathogenesis of chronic liver disease. Cancer Letters 2009; 286(1): 69 doi: 10.1016/j.canlet.2008.12.010
|
| 44 |
Yijun Wang, Danfei Liu, Tongyue Zhang, Limin Xia. FGF/FGFR Signaling in Hepatocellular Carcinoma: From Carcinogenesis to Recent Therapeutic Intervention. Cancers 2021; 13(6): 1360 doi: 10.3390/cancers13061360
|
| 45 |
Takashi Futami, Hidetsugu Okada, Rumi Kihara, Tatsuya Kawase, Ayako Nakayama, Tomoyuki Suzuki, Minoru Kameda, Nobuaki Shindoh, Tadashi Terasaka, Masaaki Hirano, Sadao Kuromitsu. ASP5878, a Novel Inhibitor of FGFR1, 2, 3, and 4, Inhibits the Growth of FGF19-Expressing Hepatocellular Carcinoma. Molecular Cancer Therapeutics 2017; 16(1): 68 doi: 10.1158/1535-7163.MCT-16-0188
|
| 46 |
Aldo Prawira, Thi Bich Uyen Le, Thanh Chung Vu, Hung Huynh. Ribociclib enhances infigratinib‐induced cancer cell differentiation and delays resistance in FGFR‐driven hepatocellular carcinoma. Liver International 2021; 41(3): 608 doi: 10.1111/liv.14728
|
| 47 |
Zhen-Chong Yang, Mei-Juan Luo, Li-Li Liu, Mu-Yan Cai, Yu-Jing Liang, Qiu-Yan Chen, Lin-Quan Tang, Hai-Qiang Mai. Alpha-fetoprotein–producing recurrent nasopharyngeal carcinoma: A case report. SAGE Open Medical Case Reports 2021; 9 doi: 10.1177/2050313X211057704
|